| Serial Number | 97407218 |
| Word Mark | SHORLA ONCOLOGY |
| Filing Date | Thursday, May 12, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 8, 2023 |
| Registration Number | 7130540 |
| Registration Date | Tuesday, August 8, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 23, 2023 |
| Goods and Services | pharmaceutical and medicinal preparations and substances for the treatment of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; pharmaceutical and medicinal preparations and substances for use in oncology; pharmaceutical preparations, products and substances for human use for the treatment of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; pharmaceutical preparations and substances for the prevention and treatment of cancer; pharmaceutical compounds for treating cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of tumours; anti-cancer drugs and pharmaceutical preparations |
| Disclaimer with Predetermined Text | "ONCOLOGY" |
| Goods and Services | research and development services in the field of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; biological research; scientific research services; research and development services in the pharmaceutical and biotechnology fields; research services relating to the development and testing of pharmaceutical preparations and medicines; pharmaceutical drug development services; pharmaceutical product evaluation; testing and inspection of pharmaceutical preparations and medicines; product safety and quality testing in the pharmaceutical and biotechnology fields; provision of information and data relating to research and development in the pharmaceutical and biotechnology fields |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 17, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 19, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Shorla Pharma Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Clonmel, Co. Tipperary E91V329 IE |
| Party Name | Shorla Pharma Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Clonmel, Co. Tipperary E91V329 IE |
| Party Name | Shorla Pharma Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Clonmel, Co. Tipperary E91V329 IE |
| Event Date | Event Description |
| Tuesday, August 8, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, August 8, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 23, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 23, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 3, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, April 19, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 19, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, April 19, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, April 19, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, April 19, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, April 6, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, April 6, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 6, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 8, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 8, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 8, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 1, 2023 | ASSIGNED TO EXAMINER |
| Saturday, September 3, 2022 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Friday, September 2, 2022 | ASSIGNED TO LIE |
| Wednesday, August 3, 2022 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Tuesday, May 17, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, May 16, 2022 | NEW APPLICATION ENTERED |